Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
Provided By GlobeNewswire
Last update: Nov 13, 2024
Generated $48.1 million in XDEMVY® net product sales driven by more than 41,400 bottles delivered to patients in the third quarter
Read more at globenewswire.com
